Olanzapine
- Product NDC
- 60505-3276
- 11-digit product format
- 605053276
- Labeler code
- 60505
- Product ID
- 60505-3276_997c6776-1ac1-bcb1-022c-2c5b6c277395
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Olanzapine
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Apotex Corp.
- Application
- ANDA091265
- Marketing category
- ANDA
- Marketing start
- 2011-10-24
- Substance
- OLANZAPINE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Olanzapine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OLANZAPINE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | N7U69T4SZR |
| Rxcui | 312076, 314155, 351107, 351108 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60505-3276-0 | Olanzapine | 10 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 10 | | 19 |
| 60505-3276-0 | Olanzapine | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | | 19 |
| 60505-3276-3 | Olanzapine | 30 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 30 | | 19 |
| 60505-3276-8 | Olanzapine | 1000 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 1000 | | 19 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| OLANZAPINE | ACTIVE INGREDIENT | N7U69T4SZR | OLANZAPINE TABLET, ORALLY DISINTEGRATING [APOTEX CORP.] | 6 | |
| OLANZAPINE | ACTIVE MOIETY | N7U69T4SZR | OLANZAPINE TABLET, ORALLY DISINTEGRATING [APOTEX CORP.] | 6 | |
| Carboxymethylcellulose Calcium | INACTIVE INGREDIENT | UTY7PDF93L | OLANZAPINE TABLET, ORALLY DISINTEGRATING [APOTEX CORP.] | 6 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | OLANZAPINE TABLET, ORALLY DISINTEGRATING [APOTEX CORP.] | 6 | |
| Colloidal Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | OLANZAPINE TABLET, ORALLY DISINTEGRATING [APOTEX CORP.] | 6 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | OLANZAPINE TABLET, ORALLY DISINTEGRATING [APOTEX CORP.] | 6 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | OLANZAPINE TABLET, ORALLY DISINTEGRATING [APOTEX CORP.] | 6 | |
| SUCRALOSE | INACTIVE INGREDIENT | 96K6UQ3ZD4 | OLANZAPINE TABLET, ORALLY DISINTEGRATING [APOTEX CORP.] | 6 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60505-3276 | OLANZAPINE TABLET, ORALLY DISINTEGRATING [APOTEX CORP.] | 19 | Current NDC, Legacy NDC, 4 package rows | 20250411_96165590-b287-0ed9-3723-752af59aedad.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-3276-0 | 60505327600 | 10 BLISTER PACK in 1 CARTON (60505-3276-0) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | 10 blister pack | 2011-10-24 | 0000-00-00 | No | No | Current |
| 60505-3276-3 | 60505327603 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (60505-3276-3) | | 2011-10-24 | 0000-00-00 | No | No | Current |
| 60505-3276-8 | 60505327608 | 1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (60505-3276-8) | | 2011-10-24 | 0000-00-00 | No | No | Current |